Evidence map›Paper›PMID 23256519›Full record

ReviewGrowth factors (Chur, Switzerland)2013

The way Wnt works: components and mechanism.

Kenyi Saito-Diaz, Tony W Chen, Xiaoxi Wang, Curtis A Thorne, Heather A Wallace, Andrea Page-McCaw, Ethan Lee

Open access · greenAbstract readReview
In one paragraph

Review in Growth factors (Chur, Switzerland), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 116 papers.

0numbers the graph read from it
0cells of the map it votes in
116citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

116 citing papers in PubMed, 213 citations in OpenAlex.

  1. Trial
  2. Article
  3. IsJournal of developmental biology · 2025
    Review
  4. Article
  5. Article
  6. Mechanistic insights into medulloblastoma relapse.Pharmacology & therapeutics · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Temporal pattern of Fos and Jun families expression after mitogenic stimulation with FGF-2 in rat neural stem cells and fibroblasts.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas · 2023
    Article
  12. Article
  13. Anti-sclerostin antibodies: a new frontier in fragility fractures treatment.Therapeutic advances in musculoskeletal disease · 2023
    Review
  14. Emerging Direct Targeting β-Catenin Agents.Molecules (Basel, Switzerland) · 2022
    Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Observational

56 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Kenyi Saito-DiazDepartment of Cell and Developmental Biology and Program in Developmental Biology, Vanderbilt University Medical Center, Nashville, TN 37232-8240, USA.
Tony W Chen
Xiaoxi Wang
Curtis A Thorne
Heather A Wallace
Andrea Page-McCaw
Ethan Lee
Center for Systems Biology · US

Funding

Understanding and Controlling p120 Dysfunction in CRCP50CA095103 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI COFFEY, ROBERT J. · 2002 to 2017
$33.6M
MULTIDISCIPLINARY TRAINING IN MOLECULAR ENDOCRINOLOGYT32DK007563 · NIDDK · VANDERBILT UNIVERSITY · PI Richard M O'Brien · 1988 to 2026
$15.9M
Integrated Biological Systems Training in OncologyT32CA119925 · NCI · VANDERBILT UNIVERSITY · PI Vivian Gama, William Patrick Tansey · 2008 to 2026
$7.6M
Matrix metalloproteinases in Drosophila wound healingR01GM073883 · NIGMS · VANDERBILT UNIVERSITY · PI PAGE-MCCAW, ANDREA · 2006 to 2015
$2.6M
Regulation of beta-catenin degradation during Wnt signal transductionR01GM081635 · NIGMS · VANDERBILT UNIVERSITY · PI LEE, ETHAN · 2007 to 2016
$2.4M
NCI NIH HHS 5T32CA11992504NCI NIH HHS GI SPORE P50 CA95103NCI NIH HHS P50 CA095103NCI NIH HHS T32 CA119925NIDDK NIH HHS T32 DK007563NIGMS NIH HHS 1 R01 GM081635-05NIGMS NIH HHS R01 GM073883NIGMS NIH HHS R01 GM081635
6 · The paper itself

Abstract

The canonical Wnt/β-catenin pathway is an ancient and evolutionarily conserved signaling pathway that is required for the proper development of all metazoans, from the basal demosponge Amphimedon queenslandica to humans. Misregulation of Wnt signaling is implicated in many human diseases, making this pathway an intense area of research in industry as well as academia. In this review, we explore our current understanding of the molecular steps involved in the transduction of a Wnt signal. We will focus on how the critical Wnt pathway component, β-catenin, is in a "futile cycle" of constant synthesis and degradation and how this cycle is disrupted upon pathway activation. We describe the role of the Wnt pathway in major human cancers and in the control of stem cell self-renewal in the developing organism and in adults. Finally, we describe well-accepted criteria that have been proposed as evidence for the involvement of a molecule in regulating the canonical Wnt pathway.

Indexed as

Wnt Signaling PathwayAnimalsbeta CateninCell DifferentiationEmbryonic Stem CellsHumansNeoplasmsWnt Proteinsbeta CateninWnt Proteins

Identifiers

PMID23256519
PMCPMC3697919
OpenAlexW2167627426

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.